AAAAAA
Results: 1-25/159
Authors:
SCHULZ JB
WELLER M
MATTHEWS RT
HENEKA MT
GROSCURTH P
MARTINOU JC
LOMMATZSCH J
VONCOELLN R
WULLNER U
LOSCHMANN PA
BEAL MF
DICHGANS J
KLOCKGETHER T
Citation: Jb. Schulz et al., EXTENDED THERAPEUTIC WINDOW FOR CASPASE INHIBITION AND SYNERGY WITH MK-801 IN THE TREATMENT OF CEREBRAL HISTOTOXIC HYPOXIA, Cell death and differentiation, 5(10), 1998, pp. 847-857
Authors:
WAGENKNECHT B
SCHULZ JB
GULBINS E
WELLER M
Citation: B. Wagenknecht et al., CRM-A, BCL-2 AND NDGA INHIBIT CD95L-INDUCED APOPTOSIS OF MALIGNANT GLIOMA-CELLS AT THE LEVEL OF CASPASE-8 PROCESSING, Cell death and differentiation, 5(10), 1998, pp. 894-900
Authors:
BRENNER B
FERLINZ K
GRASSME H
WELLER M
KOPPENHOEFER U
DICHGANS J
SANDHOFF K
LANG F
GULBINS E
Citation: B. Brenner et al., FAS CD95/APO-I ACTIVATES THE ACIDIC SPHINGOMYELINASE VIA CASPASES/, Cell death and differentiation, 5(1), 1998, pp. 29-37
Authors:
GLEICHMANN M
BEINROTH S
REED JC
KRAJEWSKI S
SCHULZ JB
WULLNER U
KLOCKGETHER T
WELLER M
Citation: M. Gleichmann et al., POTASSIUM DEPRIVATION-INDUCED APOPTOSIS OF CEREBELLAR GRANULE NEURONS- CYTOCHROME-C RELEASE IN THE ABSENCE OF ALTERED EXPRESSION OF BCL-2 FAMILY PROTEINS, Cellular physiology and biochemistry, 8(4), 1998, pp. 194-201
Authors:
WELLER M
KLEIHUES P
DICHGANS J
OHGAKI H
Citation: M. Weller et al., CD95 LIGAND - LETHAL WEAPON AGAINST MALIGNANT GLIOMA, Brain pathology, 8(2), 1998, pp. 285-293
Authors:
STANDER M
NAUMANN U
DUMITRESCU L
HENEKA M
LOSCHMANN P
GULBINS E
DICHGANS J
WELLER M
Citation: M. Stander et al., DECORIN GENE TRANSFER-MEDIATED SUPPRESSION OF TGF-BETA SYNTHESIS ABROGATES EXPERIMENTAL MALIGNANT GLIOMA GROWTH IN-VIVO, Gene therapy, 5(9), 1998, pp. 1187-1194
Authors:
SCHULZ JB
MATTHEWS RT
HENEKA M
VONCOELLP R
BEAL MF
KLOCKGETHER T
WELLER M
Citation: Jb. Schulz et al., EXTENDED THERAPEUTIC WINDOW FOR CASPASE INHIBITION AND SYNERGY WITH MK-801 IN THE TREATMENT OF CEREBRAL HISTOTOXIC HYPOXIA, European journal of neuroscience, 10, 1998, pp. 803-803
Authors:
RIEGER J
STANDER M
LOSCHMANN PA
HENEKA M
DICHGANS J
KLOCKGETHER T
WELLER M
Citation: J. Rieger et al., SYNTHESIS AND BIOLOGICAL EFFECTS OF NO IN MALIGNANT GLIOMA-CELLS - MODULATION BY CYTOKINES INCLUDING CD95L AND TGF-BETA, DEXAMETHASONE, ANDP53 GENE-TRANSFER, Oncogene, 17(18), 1998, pp. 2323-2332
Authors:
NAUMANN U
DURKA S
WELLER M
Citation: U. Naumann et al., DEXAMETHASONE-MEDIATED PROTECTION FROM DRUG CYTOTOXICITY - ASSOCIATION WITH P21(WAF1 CIP1) PROTEIN ACCUMULATION/, Oncogene, 17(12), 1998, pp. 1567-1575
Authors:
ZIPP F
MARTIN R
DICHGANS J
WELLER M
Citation: F. Zipp et al., CD95 (APO-1 FAS) AND PARKINSONS-DISEASE - REPLY/, Annals of neurology, 44(3), 1998, pp. 426-426
Authors:
ZIPP F
WELLER M
CALABRESI PA
FRANK JA
BASH CN
DICHGANS J
MCFARLAND HF
MARTIN R
Citation: F. Zipp et al., INCREASED SERUM LEVELS OF SOLUBLE CD95 (APO-1 FAS) IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS/, Annals of neurology, 43(1), 1998, pp. 116-120
Authors:
ABELE M
LEONHARDT M
DICHGANS J
WELLER M
Citation: M. Abele et al., CCNU OVERDOSE DURING PCV CHEMOTHERAPY FOR ANAPLASTIC ASTROCYTOMA, Journal of neurology, 245(4), 1998, pp. 236-238
Authors:
WELLER M
BORNEMANN A
STANDER M
SCHABET M
DICHGANS J
MEYERMANN R
Citation: M. Weller et al., HUMORAL IMMUNE-RESPONSE TO P53 IN MALIGNANT GLIOMA, Journal of neurology, 245(3), 1998, pp. 169-172
Authors:
WELLER M
KLOCKGETHER T
Citation: M. Weller et T. Klockgether, MINOCYCLINE-INDUCED BENIGN INTRACRANIAL HYPERTENSION, Journal of neurology, 245(1), 1998, pp. 55-55
Authors:
SCHULZ JB
BEINROTH S
WELLER M
WULLNER U
KLOCKGETHER T
Citation: Jb. Schulz et al., ENDONUCLEOLYTIC DNA FRAGMENTATION IS NOT REQUIRED FOR APOPTOSIS OF CULTURED RAT CEREBELLAR GRANULE NEURONS, Neuroscience letters, 245(1), 1998, pp. 9-12
Authors:
WELLER M
SCHUSTER M
PIETSCH T
SCHABET M
Citation: M. Weller et al., CD95 LIGAND-INDUCED APOPTOSIS OF HUMAN MEDULLOBLASTOMA CELLS, Cancer letters, 128(2), 1998, pp. 121-126
Authors:
WELLER M
Citation: M. Weller, PREDICTING RESPONSE TO CANCER-CHEMOTHERAPY - THE ROLE OF P53, Cell and tissue research, 292(3), 1998, pp. 435-445
Authors:
TREPEL M
GROSCURTH P
MALIPIERO U
GULBINS E
DICHGANS J
WELLER M
Citation: M. Trepel et al., CHEMOSENSITIVITY OF HUMAN-MALIGNANT GLIOMA - MODULATION BY P53 GENE-TRANSFER, Journal of neuro-oncology, 39(1), 1998, pp. 19-32
Authors:
HERRLINGER U
WELLER M
SCHABET M
Citation: U. Herrlinger et al., NEW ASPECTS OF IMMUNOTHERAPY OF LEPTOMENINGEAL METASTASIS, Journal of neuro-oncology, 38(2-3), 1998, pp. 233-239
Authors:
STANDER M
DICHGANS J
WELLER M
Citation: M. Stander et al., ANTICONVULSANT DRUGS FAIL TO MODULATE CHEMOTHERAPY-INDUCED CYTOTOXICITY AND GROWTH-INHIBITION OF HUMAN-MALIGNANT GLIOMA-CELLS, Journal of neuro-oncology, 37(3), 1998, pp. 191-198
Authors:
ROTH W
WAGENKNECHT B
DICHGANS J
WELLER M
Citation: W. Roth et al., INTERFERON-ALPHA ENHANCES CD95L-INDUCED APOPTOSIS OF HUMAN-MALIGNANT GLIOMA-CELLS, Journal of neuroimmunology, 87(1-2), 1998, pp. 121-129
Authors:
ZIPP F
OTZELBERGER K
DICHGANS J
MARTIN R
WELLER M
Citation: F. Zipp et al., SERUM CD95 OF RELAPSING-REMITTING MULTIPLE-SCLEROSIS PATIENTS PROTECTS FROM CD95-MEDIATED APOPTOSIS, Journal of neuroimmunology, 86(2), 1998, pp. 151-154
Authors:
ZIPP F
FABER E
SOMMER N
MULLER C
DICHGANS J
KRAMMER PH
MARTIN R
WELLER M
Citation: F. Zipp et al., CD95 EXPRESSION AND CD95-MEDIATED APOPTOSIS OF T-CELLS IN MULTIPLE-SCLEROSIS - NO DIFFERENCES FROM NORMAL INDIVIDUALS AND NO RELATION TO HLA-DR2, Journal of neuroimmunology, 81(1-2), 1998, pp. 168-172
Authors:
ESSER P
TERVOOREN D
HEIMANN K
KOCIOK N
BARTZSCHMIDT K
WALTER P
WELLER M
Citation: P. Esser et al., INTRAVITREAL DAUNOMYCIN INDUCES MULTIDRUG-RESISTANCE IN PROLIFERATIVEVITREORETINOPATHY, Investigative ophthalmology & visual science, 39(1), 1998, pp. 164-170
Authors:
WELLER M
Citation: M. Weller, SCHIZOPHRENIAS COMPLEXITIES BEGIN TO YIELD, Lancet, 351(9103), 1998, pp. 652-652